search
Back to results

Routine Early vs Delayed Amniotomy for Preterm Pregnancies: A Randomized Open Label Trial (Cereal)

Primary Purpose

Labor, Premature

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Early Artificial rupture of membranes
Delayed Artificial rupture of membranes
Sponsored by
The University of Texas Health Science Center, Houston
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Labor, Premature focused on measuring Pregnancy, labor induction, preterm

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Preterm singleton pregnancy between 28.0 and 36.6 completed weeks of gestation
  • Fetus in the cephalic position
  • Intent to induce labor for vaginal delivery
  • If cervical ripening is planned, patient must be enrolled within an hour of initiation of ripening. If no ripening is planned, enrollment must be complete prior to starting induction.

Exclusion Criteria:

  • Preterm premature rupture of membranes (PPROM)
  • Fever or suspected chorioamnionitis prior to start of IOL
  • Prior uterine scar
  • Infection with HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) or an active Herpes Simplex Virus (HSV) infection
  • Intrauterine fetal demise
  • Major fetal anomaly
  • Cervical dilation > 4 cm

Sites / Locations

  • University of Texas Health Science Center of Houston

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Early artificial rupture of membranes

Delayed artificial rupture of membranes

Arm Description

Women in this arm will undergo artificial rupture of membranes before 4 cm of cervical dilation is reached during induction of labor as long as the procedure is deemed clinically safe and feasible.

Women in this arm may undergo artificial rupture of membranes performed only after 4 cm of cervical dilation is reached during induction of labor. Rupture may also be performed after 10 hours of oxytocin administration with no cervical change.

Outcomes

Primary Outcome Measures

Total duration of labor.
The duration of labor begins with administration of the first induction agent (i.e. Cook balloon, Foley catheter, prostaglandins, or oxytocin) and ends with delivery.

Secondary Outcome Measures

Labor Outcomes:Time from completion of cervical ripening to delivery
When the last induction agent is a foley/Cook balloon, or cervidil (dinoprostone), "completion of cervical ripening" will be defined as the time when the agent is removed. When the last induction agent is misoprostol, "completion of cervical ripening" will be defined as 4 hours after administration of the last dose.
Labor Outcomes: Delivery before 24 hours from start of Induction of Labor (IOL)
A dichotomization of duration of labor
Labor Outcomes: Duration of the 2nd stage of labor
Defined as time from the first cervical exam with complete dilation and effacement to the time of delivery
Maternal Outcome:Cesarean delivery
Mode of delivery
Maternal/Labor Outcomes: Indication for Cesarean delivery
Reason for cesarean delivery
Maternal/Labor Outcomes:Operative vaginal delivery
Use of either a vacuum device or obstetrical forceps
Maternal intrapartum fever or chorioamnionitis
Defined as persistent intrapartum fever and/or suspected or confirmed intraamniotic infection (20)
Post-partum endometritis:
defined as postpartum febrile morbidity in the absence of another causative factor (i.e. wound infection, deep venous thrombosis). Postpartum febrile morbidity is defined as oral temperature ≥ 38.0⁰ C on any 2 of the first 10 days postpartum, exclusive of the first postpartum day
Epidural anesthesia
Use of epidural regional anesthesia for pain control during induction of labor
Recurrent variable or late decelerations
As defined by The American College of Obstetrics and Gynecology ( ACOG), practice bulletin No 110
Meconium stained amniotic fluid
Meconium is noted in the amniotic fluid after rupture of membranes
Tachysystole
As defined by ACOG, practice bulletin No 110
Use of amnioinfusion
Placement of an intrauterine catheter and infusion of saline into the uterus during induction of labor
Use of intrapartum tocolytics
Administration of a tocolytic drug during labor

Full Information

First Posted
September 21, 2018
Last Updated
April 29, 2021
Sponsor
The University of Texas Health Science Center, Houston
search

1. Study Identification

Unique Protocol Identification Number
NCT03682822
Brief Title
Routine Early vs Delayed Amniotomy for Preterm Pregnancies: A Randomized Open Label Trial
Acronym
Cereal
Official Title
Comparative Effectiveness of Routine Early Versus Delayed Amniotomy for Pregnancies Less Than 37 Weeks Gestational Age: A Randomized Open Label Trial (CEREAL)
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Terminated
Why Stopped
Covid
Study Start Date
November 1, 2018 (Actual)
Primary Completion Date
February 22, 2020 (Actual)
Study Completion Date
February 24, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of Texas Health Science Center, Houston

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
To compare the duration of preterm induction of labor in women undergoing early vs. late or no artificial rupture of membranes (AROM). Maternal and neonatal outcomes will also be compared between the two groups.
Detailed Description
Women presenting with a preterm singleton pregnancy between 28.0 and 36.6 weeks of gestation with cephalic lie and a medical indication for induction of labor will be approached for this study. The patient/provider must be attempting induction with the goal of vaginal delivery. Women with ruptured membranes, suspected intrauterine infection, prior uterine scar, fetal demise, or a fetal anomaly will be excluded. Women that agree to the study will be randomized to 2 groups: the "early amniotomy" group and the "late amniotomy" group. Women in the early amniotomy group will undergo artificial rupture of membranes (AROM) prior to reaching cervical dilation of 4 cm. Women in the late amniotomy group may not undergo AROM until they reach cervical dilation of greater than 4 cm or they have been on an oxytocin drip for greater than 10 hours with no cervical change. It is possible that a woman in the late amniotomy group will not undergo AROM at all. The primary outcome under consideration is time in labor. Secondary outcomes include rates of chorioamnionitis, postpartum endometritis, mode of delivery, and neonatal outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Labor, Premature
Keywords
Pregnancy, labor induction, preterm

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
104 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Early artificial rupture of membranes
Arm Type
Experimental
Arm Description
Women in this arm will undergo artificial rupture of membranes before 4 cm of cervical dilation is reached during induction of labor as long as the procedure is deemed clinically safe and feasible.
Arm Title
Delayed artificial rupture of membranes
Arm Type
Active Comparator
Arm Description
Women in this arm may undergo artificial rupture of membranes performed only after 4 cm of cervical dilation is reached during induction of labor. Rupture may also be performed after 10 hours of oxytocin administration with no cervical change.
Intervention Type
Procedure
Intervention Name(s)
Early Artificial rupture of membranes
Intervention Description
Women in this arm will undergo artificial rupture of membranes before 4 cm of cervical dilation is reached during induction of labor as long as the procedure is deemed clinically safe and feasible.
Intervention Type
Procedure
Intervention Name(s)
Delayed Artificial rupture of membranes
Intervention Description
Women in this arm may undergo artificial rupture of membranes performed only after 4 cm of cervical dilation is reached during induction of labor. Rupture may also be performed after 10 hours of oxytocin administration with no cervical change.
Primary Outcome Measure Information:
Title
Total duration of labor.
Description
The duration of labor begins with administration of the first induction agent (i.e. Cook balloon, Foley catheter, prostaglandins, or oxytocin) and ends with delivery.
Time Frame
Induction of labor until delivery (1 hr - 48 hrs)
Secondary Outcome Measure Information:
Title
Labor Outcomes:Time from completion of cervical ripening to delivery
Description
When the last induction agent is a foley/Cook balloon, or cervidil (dinoprostone), "completion of cervical ripening" will be defined as the time when the agent is removed. When the last induction agent is misoprostol, "completion of cervical ripening" will be defined as 4 hours after administration of the last dose.
Time Frame
Induction of labor until delivery (1 hr - 48 hrs)
Title
Labor Outcomes: Delivery before 24 hours from start of Induction of Labor (IOL)
Description
A dichotomization of duration of labor
Time Frame
Induction of labor until delivery (1 hr - 48 hrs)
Title
Labor Outcomes: Duration of the 2nd stage of labor
Description
Defined as time from the first cervical exam with complete dilation and effacement to the time of delivery
Time Frame
Induction of labor until delivery (1 hr - 48 hrs)
Title
Maternal Outcome:Cesarean delivery
Description
Mode of delivery
Time Frame
at delivery
Title
Maternal/Labor Outcomes: Indication for Cesarean delivery
Description
Reason for cesarean delivery
Time Frame
at delivery
Title
Maternal/Labor Outcomes:Operative vaginal delivery
Description
Use of either a vacuum device or obstetrical forceps
Time Frame
at delivery
Title
Maternal intrapartum fever or chorioamnionitis
Description
Defined as persistent intrapartum fever and/or suspected or confirmed intraamniotic infection (20)
Time Frame
during labor to delivery
Title
Post-partum endometritis:
Description
defined as postpartum febrile morbidity in the absence of another causative factor (i.e. wound infection, deep venous thrombosis). Postpartum febrile morbidity is defined as oral temperature ≥ 38.0⁰ C on any 2 of the first 10 days postpartum, exclusive of the first postpartum day
Time Frame
up to 10 days
Title
Epidural anesthesia
Description
Use of epidural regional anesthesia for pain control during induction of labor
Time Frame
during labor
Title
Recurrent variable or late decelerations
Description
As defined by The American College of Obstetrics and Gynecology ( ACOG), practice bulletin No 110
Time Frame
during labor
Title
Meconium stained amniotic fluid
Description
Meconium is noted in the amniotic fluid after rupture of membranes
Time Frame
during labor and delivery
Title
Tachysystole
Description
As defined by ACOG, practice bulletin No 110
Time Frame
during labor
Title
Use of amnioinfusion
Description
Placement of an intrauterine catheter and infusion of saline into the uterus during induction of labor
Time Frame
during labor
Title
Use of intrapartum tocolytics
Description
Administration of a tocolytic drug during labor
Time Frame
during labor

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Preterm singleton pregnancy between 28.0 and 36.6 completed weeks of gestation Fetus in the cephalic position Intent to induce labor for vaginal delivery If cervical ripening is planned, patient must be enrolled within an hour of initiation of ripening. If no ripening is planned, enrollment must be complete prior to starting induction. Exclusion Criteria: Preterm premature rupture of membranes (PPROM) Fever or suspected chorioamnionitis prior to start of IOL Prior uterine scar Infection with HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) or an active Herpes Simplex Virus (HSV) infection Intrauterine fetal demise Major fetal anomaly Cervical dilation > 4 cm
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Clifton O Brock, MD
Organizational Affiliation
University of Texas Health Science Center of Houston
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Texas Health Science Center of Houston
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Routine Early vs Delayed Amniotomy for Preterm Pregnancies: A Randomized Open Label Trial

We'll reach out to this number within 24 hrs